Question

Biotrue produces tissues and diagnostics substances for three market segments: hospitals, universities, and pharmaceutical companies. The firm is trying to decide whether to decentralize its R&D activities by division or not. You have been called in as a consultant to explain the advantages and disadvantages of such a move. What will your opinion be?

Answer

This answer is hidden. It contains 604 characters.